Men (n = 20) | Women (n = 36) | P value | |
---|---|---|---|
Agea | 55.9 ± 16.4 | 59.1 ± 10.5 | 0.86 |
Admission mFa | 2.7 ± 1.1 | 3.3 ± 1.1 | 0.056 |
Admission HHa | 2.5 ± 1.7 | 2.9 ± 1.3 | 0.33 |
Admission GCS | 14.5 (6.5–15) | 13 (8.5–15) | 0.35 |
Admission WFNS | 1.5 (1–4.5) | 2 (1–4) | 0.45 |
Hydrocephalus | 11 (55.0%) | 28 (77.8%) | 0.076 |
EVD+ | 7 (35.0%) | 24 (66.7%) | 0.022 |
Aneurysm treatment | 0.082 | ||
Clip | 2 (10.0%) | 12 (33.3%) | |
Coil | 9 (45.0%) | 16 (44.4%) | |
Otherb | 9 (45.0%) | 8 (22.2%) | |
Days from SAH to MRI | 5.5 (3.5–11.5) | 7 (3.5–13.5) | 0.64 |
DCI or vasospasm | 8 (40.0%) | 21 (58.3%) | 0.19 |
ICU LOS | 11.5 (6.5–18.5) | 18 (13.5–25) | 0.014 |
Hospital LOS | 13.5 (10.5–27) | 20.5 (16.5–34) | 0.015 |
Days with EVD among EVD+ | 14 (10–22) | 18 (13.5–24) | 0.24 |
EVD complications | 1 (14.3%) | 19 (79.2%) | 0.002 |
Ventriculitis | 0 (0%) | 3 (12.5%) | 0.33 |
Tract hemorrhage | 1 (14.3%) | 18 (75.0%) | 0.004 |
Overdrainage | 0 (0%) | 3 (12.5%) | 0.33 |
Received VPS among EVD+ | 2 (28.5%) | 6 (25.0%) | 0.85 |
mRS at discharge | 3 (2–3.5) | 4 (3–5) | 0.011 |
mRS at 6 months | 1.5 (0–5) | 2 (1–5) | 0.65 |